首页> 外文OA文献 >Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study)

【2h】

Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study)

机译：转移性结肠直肠癌稀有BRAF突变的临床，病理和预后特征（MCRC）：双制度回顾性分析（Rebus Study）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Maria Alessandra Calegari; Lisa Salvatore; Brunella Di Stefano; Michele Basso; Armando Orlandi; Alessandra Boccaccino; Fiorella Lombardo; Alessandra Auriemma; Ina Valeria Zurlo; Maria Bensi; Floriana Camarda; Marta Ribelli; Raffaella Vivolo; Alessandra Cocomazzi; Carmelo Pozzo; Michele Milella; Maurizio Martini; Emilio Bria; Giampaolo Tortora;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinicopathologic features and prognostic value of KRAS KRAS , NRAS NRAS and BRAF BRAF mutations and DNA mismatch repair status: A single‐center retrospective study of 1,834 Chinese patients with Stage I–IV colorectal cancer [J] . Guo Tian‐An, Wu Yu‐Chen, Tan Cong, International Journal of Cancer =: Journal International du Cancer . 2019,第6期

机译：KRAS KRAS，NRAS NRAS和BRAF BRAF突变和DNA错配修复状态的临床病理特征及预后价值：1,834例中国阶段I-IV型结直肠癌患者的单中心回顾性研究
2. 6077 A meta-analysis of the CRYSTAL and OPUS studies combining cetuximab with chemotherapy (CT) as 1st-line treatment for patients (pts) with metastatic colorectal cancer (mCRC): Results according to KRAS and BRAF mutation status [J] . E.Van Cutsem, P.Rougier, C.K?hne, European Journal of Cancer Supplements . 2009,第2期

机译：6077对西妥昔单抗联合化疗（CT）作为转移性结直肠癌（mCRC）患者（pts）的一线治疗的CRYSTAL和OPUS研究的荟萃分析：根据KRAS和BRAF突变状态得出的结果
3. BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features [J] . Roma Cristin, Rachiglio Anna Maria, Pasquale Raffaella, Cancer biology & therapy . 2016,第8期

机译：转移性结直肠癌中的BRAF V600E突变：检测方法及其与临床和病理特征的相关性
4. Single Cell Genomic Profiling of Circulating Tumor Cells (CTCs) from Metastatic Colorectal Cancer (mCRC) Identify Tumor Heterogeneity and Rare Somatic Driver Alterations [C] . Stephanie Greene, Angel Rodriguez, Jerry Lee, International Molecular Medicine Tri-Conference. . 2016

机译：转移结直肠癌（MCRC）的循环肿瘤细胞（CTC）的单细胞基因组分析识别肿瘤异质性和稀有躯体驾驶员改变
5. Identifying Prognostic Gene Mutations in Colorectal Cancer with Random Forest Survival Analysis [D] . Chen, Zihang. 2020

机译：用随机林生存分析确定结肠直肠癌中的预后基因突变
6. Clinical Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study) [O] . Maria Alessandra Calegari, Lisa Salvatore, Brunella Di Stefano, 2021

机译：转移性结肠直肠癌稀有BRAF突变的临床病理和预后特征（MCRC）：双制度回顾性分析（Rebus Study）
7. Clinical, pathological, and prognostic features of rare BRAF mutations in metastatic colorectal cancer: a bi-institutional retrospective analysis (REBUS study) [O] . M. Bensi, M. Calegari, M. Basso, 2019

机译：转移性结肠直肠癌稀有BRAF突变的临床，病理和预后特征：双制度回顾性分析（Rebus学习）

Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study)

著录项

引文网络

相似文献

相关主题

期刊订阅